X0206 3 2018-06-27 0 0001595585 Tricida, Inc. TCDA 0001572451 Bonita David P 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 true true Series A Convertible Preferred Stock Common Stock 1559716 I By OrbiMed Private Investments V, LP Series B Convertible Preferred Stock Common Stock 4300774 I By OrbiMed Private Investments V, LP Series C Convertible Preferred Stock Common Stock 3591194 I By OrbiMed Private Investments V, LP Series D Convertible Preferred Stock Common Stock 1069175 I By OrbiMed Private Investments V, LP Each of the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock is convertible at any time at the option of the holder (and is automatically convertible upon closing of the Issuer's initial public offering of its Common Stock) into Common Stock at a rate of 1/3.98, for no additional consideration, and has no expiration date. These shares are held directly by OrbiMed Private Investments V, LP ("OPI V"). OrbiMed Capital GP V LLC ("OrbiMed GP") is the sole general partner of OPI V, and OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered adviser under the Investment Advisers Act of 1940, as amended, is the sole managing member of OrbiMed GP. The Reporting Person is an employee of OrbiMed Advisors. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. /s/ David P. Bonita 2018-06-27